Cooper City, FL, United States of America

Jane Chang Chen

This inventor holds 1 USPTO granted patent. Top assignee: Andrx Pharmaceuticals, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jane Chang Chen. Retrieved from https://idiyas.com/inventor/jane-chang-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jane Chang Chen

Introduction

Jane Chang Chen is an accomplished inventor based in Cooper City, FL (US). She has made significant contributions to the field of pharmaceuticals, particularly with her innovative work on controlled release formulations.

Latest Patents

Jane holds a patent for a "Controlled release formulation of captopril or a prodrug of captopril." This invention provides a controlled release pharmaceutical unit dose composition for oral administration. The composition includes an internal phase comprising captopril or a prodrug of captopril mixed with a hydrogel forming agent, and an external phase that features a coating resistant to dissolution in the stomach. She has 1 patent to her name.

Career Highlights

Jane is currently employed at Andrx Pharmaceuticals, Inc., where she continues to develop innovative pharmaceutical solutions. Her work has been instrumental in advancing drug delivery systems, enhancing the efficacy and safety of medications.

Collaborations

Jane has collaborated with notable colleagues, including Jainbo Xie and Elliot F Hahn, contributing to a dynamic and innovative work environment.

Conclusion

Jane Chang Chen's contributions to pharmaceutical innovations exemplify her dedication to improving drug formulations. Her work not only showcases her inventive spirit but also highlights the importance of collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…